RPS6KA1 and head and neck squamous cell carcinoma: These include KSR1 (KSR1), CRAF/RAF1 (RAF1), ERK (MAPK1) and RSK1 (RPS6KA1), which are involved in the ERK signaling pathway, suggesting that interfering with ERK activation renders HNSCC cells more sensitive to mTOR inhibition.